Article

Not Enough Cancer Drugs, Too Many Price Controls

Cancer patients face daunting challenges, including side effects of treatment, impact on family life and work disruptions. They now face another problem: shortages of vital drugs.

Imagine an oncologist talking to his patient: Everything is going well with your treatment, he says, but one of the drugs you've been receiving is unavailable. There's a substitute—sort of. Your Medicare copayment for the drug we've been using is $9. Now it will cost you $520 each time the substitute is given.

Read the full story: http://on.wsj.com/SQoOVB

Source: The Wall Street Journal

Related Videos
Nini Wu, MD, Navista
John Barkett, MBA
John Barkett, MBA
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Dr Mingyang Song
John Michael O'Brien, PharmD, MPH
Lalan Wilfong, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo